Plain-English translation of NCT07714746 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
Pakistan
Large-scale testing
Sponsor
National Institute of Cardiovascular Diseases, Pakistan
Enrollment target
~200 participants
Started
April 2026
Primary completion
May 2027
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Umair Saleem, MBBS
National Institute of Cardiovascular Diseases
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.